Discontinued — last reported Q4 '23
Europe — Long-lived tangible assets
Edwards Lifesciences Europe — Long-lived tangible assets increased by 2.4% to $196.40M in Q4 2023 compared to the prior quarter. Year-over-year, this metric grew by 2.4%, from $191.80M to $196.40M.
Analysis
How to read this metric
An increase suggests capital expansion or investment in regional infrastructure, while a decrease may indicate asset depreciation, divestiture, or a shift toward asset-light operational models.
Detailed definition
This metric represents the total book value of non-current, physical assets held by the company within the European geog...
Peer comparison
Peers in the medical device sector typically report this as part of their regional property, plant, and equipment disclosures, often benchmarking it against regional revenue to assess asset turnover efficiency.
ew_segment_europe_long_lived_tangible_assetsHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q4 '22 | Q4 '23 | |
|---|---|---|---|---|---|
| Value | $209.50M | $203.80M | $197.90M | $191.80M | $196.40M |
| QoQ Change | — | -2.7% | -2.9% | -3.1% | +2.4% |
| YoY Change | — | — | — | -3.1% | +2.4% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Edwards Lifesciences's europe — long-lived tangible assets?
- Edwards Lifesciences (EW) reported europe — long-lived tangible assets of $196.40M in Q4 2023.
- How has Edwards Lifesciences's europe — long-lived tangible assets changed year-over-year?
- Edwards Lifesciences's europe — long-lived tangible assets increased by 2.4% year-over-year, from $191.80M to $196.40M.
- What does europe — long-lived tangible assets mean?
- The total value of physical, long-term assets owned by the company in the European region.